TCRX Latest Press Releases

-- July 29, 2026 --

TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2 , a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies Globe Newswire 7:00 AM

-- June 24, 2026 --

TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Globe Newswire 7:00 AM

-- June 22, 2026 --

TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation Globe Newswire 7:00 AM

-- June 3, 2026 --

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies Business Wire 9:19 AM

-- May 6, 2026 --

TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- April 27, 2026 --

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting Globe Newswire 4:30 PM

-- April 8, 2026 --

TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software